On January 5, JIUMAOJIU (09922) spent 2.023 million Hong Kong dollars to repurchase 1.066 million shares.

18:43 05/01/2026

"09922 announced on January 5, 2026, the company will spend 2.0023 million Hong Kong dollars to repurchase 1.066 million shares, with a repurchase price of 1.86-1.89 Hong Kong dollars per share."

JIUMAOJIU (09922) announced that on January 5, 2026, the company spent 2.0023 million Hong Kong dollars to repurchase 1.066 million shares, with a repurchase price of 1.86-1.89 Hong Kong dollars per share.

Chairman Zheng Jiachun increased his holding of CHOW TAI FOOK (01929) by 30,000 shares at a price of approximately HK$10.76 per share.

Chairman Pan Binze increases his holdings in TEXWINCA HOLD (00321) by 2.76 million shares at a price of approximately 1.21 Hong Kong dollars per share.

CICC: Maintain "Buy" rating on HANSOH PHARMA (03692), raise target price to HK$46.41

Chairman Zheng Jiachun increased his holding of CHOW TAI FOOK (01929) by 30,000 shares at a price of approximately HK$10.76 per share.

Chairman Pan Binze increases his holdings in TEXWINCA HOLD (00321) by 2.76 million shares at a price of approximately 1.21 Hong Kong dollars per share.

CICC: Maintain "Buy" rating on HANSOH PHARMA (03692), raise target price to HK$46.41